Heron Therapeutics, Inc.
HRTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000818033
No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
Holders of 5% or more of HRTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Heron Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Rubric Capital Management LP | 13D/A | 15.90%30.0M shares | −1.60 ppfrom 17.50% | Feb 6, 20236 filings | Oct 17, 2025 | SEC |
| Clearline Capital LP | 13G/A | 6.70%12.2M shares | +1.40 ppfrom 5.30% | Nov 26, 20252 filings | Feb 17, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
51 Schedule 13D and 13G filings on Heron Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 13, 20269:05 AM ET | Adage Capital Management, L.P.and 2 others | 13G/A | 0.00%0 shares | –Below 5% | Mar 31, 2026 | SEC |
| Mar 27, 20269:30 AM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −5.35 ppfrom 5.35%Below 5% | Mar 13, 2026 | SEC |
| Feb 17, 20262:40 PM ET | Clearline Capital LPand 2 others | 13G/A | 6.70%12.2M shares | +1.40 ppfrom 5.30% | Dec 31, 2025 | SEC |
| Jan 30, 20262:20 PM ET | Vanguard Group Inc | 13G | 5.35%9.82M shares | +0.74 ppfrom 4.61% | Dec 31, 2025 | SEC |
| Nov 26, 202510:15 AM ET | Clearline Capital LPand 2 others | 13G | 5.30%9.71M shares | New | Sep 30, 2025 | SEC |
| Oct 30, 20253:16 PM ET | Vanguard Group Inc | 13G/A | 4.61%8.46M shares | –Below 5% | Sep 30, 2025 | SEC |
| Oct 17, 20256:02 PM ET | Rubric Capital Management LPand 1 other | 13D/A | 15.90%30.0M shares | −1.60 ppfrom 17.50% | Oct 15, 2025 | SEC |
| Aug 12, 20256:00 PM ET | Rubric Capital Management LPand 1 other | 13D/A | 17.50%29.1M shares | – | Aug 8, 2025 | SEC |
| Nov 12, 2024 | Adage Capital Management, L.P. | 13GOld format | – | New | – | SEC |
| Nov 8, 2024 | BlackRock, Inc. | 13GOld format | – | – | – | SEC |
| Oct 24, 2024 | BlackRock, Inc. | 13GOld format | – | New | – | SEC |
| May 31, 2024 | Rubric Capital Management LP | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Great Point Partners LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Deep Track Capital, LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Baker Bros. Advisors LP | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 6, 2024 | Franklin Resources Inc | 13G/AOld format | – | – | – | SEC |
| Dec 7, 2023 | JPMorgan Chase & Co | 13G/AOld format | – | – | – | SEC |
| Dec 6, 20234:47 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jul 25, 2023 | Rubric Capital Management LP | 13D/AOld format | – | – | – | SEC |
| Apr 13, 2023 | Great Point Partners LLC | 13GOld format | – | New | – | SEC |
| Feb 22, 2023 | Rubric Capital Management LP | 13D/AOld format | – | – | – | SEC |
| Feb 15, 2023 | ArrowMark Colorado Holdings LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Tang Capital Partners LP | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2023 | UBS Oconnor LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 6, 2023 | Rubric Capital Management LP | 13DOld format | – | New | – | SEC |
| Feb 3, 20234:27 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 31, 2023 | Franklin Resources Inc | 13G/AOld format | – | – | – | SEC |
| Jan 23, 2023 | JPMorgan Chase & Co | 13G/AOld format | – | – | – | SEC |
| Jan 10, 2023 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Aug 19, 2022 | Deep Track Capital, LP | 13GOld format | – | New | – | SEC |
| Apr 11, 2022 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Tang Capital Partners LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | UBS Oconnor LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | ArrowMark Colorado Holdings LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Baker Bros. Advisors LP | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | State Street Corp | 13GOld format | – | New | – | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 4, 2022 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Feb 3, 2022 | Franklin Resources Inc | 13G/AOld format | – | – | – | SEC |
| Feb 1, 20225:08 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 24, 2022 | JPMorgan Chase & Co | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Tang Capital Partners LP | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | ArrowMark Colorado Holdings LLC | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Baker Bros. Advisors LP | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Janus Henderson Group PLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 4, 2021 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Feb 1, 2021 | Franklin Resources Inc | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Heron Therapeutics, Inc. shares.
No Form 144 notices for Heron Therapeutics, Inc. are on file.